G S Pharmbutor Profile
Key Indicators
- Authorised Capital ₹ 11.00 Cr
as on 15-06-2024
- Paid Up Capital ₹ 9.50 M
as on 15-06-2024
- Company Age 39 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 307.93 Cr
as on 15-06-2024
- Satisfied Charges ₹ 391.09 Cr
as on 15-06-2024
- Revenue 6.19%
(FY 2023)
- Profit -21.60%
(FY 2023)
- Ebitda -16.22%
(FY 2023)
- Net Worth 14.68%
(FY 2023)
- Total Assets 7.92%
(FY 2023)
About G S Pharmbutor
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 11.00 Cr and a paid-up capital of Rs 9.50 M.
The company currently has active open charges totaling ₹307.93 Cr. The company has closed loans amounting to ₹391.09 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at G S Pharmbutor Private Limited India is Vaishali as COMPANY SECRETARY. Usha Luthra and Vijay Modi serve as directors at the Company.
- CIN/LLPIN
U74899UR1985PTC032852
- Company No.
032852
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Mar 1985
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Rudrapur, Uttarakhand, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at G S Pharmbutor?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vaishali | Company Secretary | 07-Jul-2021 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Usha Luthra  | Director | 08-Jan-1996 | Current |
| Vijay Modi | Director | 09-Dec-2020 | Current |
Financial Performance of G S Pharmbutor.
G S Pharmbutor Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.19% increase. The company also saw a substantial fall in profitability, with a 21.6% decrease in profit. The company's net worth Soared by an impressive increase of 14.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of G S Pharmbutor?
In 2023, G S Pharmbutor had a promoter holding of 99.99% and a public holding of 0.01%. The company had 2 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_LIMITED.webp)
Modi-Mundipharma Beauty Products Private LimitedActive 30 years 10 monthsVijay Modi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Tata Capital Financial Services Limited Creation Date: 21 Feb 2023 | ₹3.40 Cr | Open |
Others Creation Date: 26 Jul 2022 | ₹20.00 Cr | Open |
Others Creation Date: 22 Jul 2022 | ₹5.00 Cr | Open |
How Many Employees Work at G S Pharmbutor?
G S Pharmbutor has a workforce of 182 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of G S Pharmbutor, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped G S Pharmbutor's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
